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Abstract
Background: Although p75 neurotrophin receptor (p75NTR) is the first neurotrophin receptor isolated, its diverse
physiological functions and signaling have remained elusive for many years. Loss-of-function phenotypic analyses for
p75NTR were mainly focused at the genetic level; however these approaches were impacted by off-target effect, insufficient
stability, unspecific stress response or alternative active splicing products. In this study, p75NTR surface expression was
suppressed for the first time at the protein level by endoplasmic reticulum (ER) retained intrabodies.
Results: Three monoclonal recombinant antibody fragments (scFv) with affinities in the low nanomolar range to murine
p75NTR were isolated by antibody phage display. To suppress p75NTR cell surface expression, the encoding genes of these
scFvs extended by the ER retention peptide KDEL were transiently transfected into the neuron-like rat pheochromocytoma
cell line PC12 and the mouse neuroblastoma x mouse spinal cord hybrid cell line NSC19. The ER retained intrabody
construct, SH325-G7-KDEL, mediated a downregulation of p75NTR cell surface expression as shown by flow cytometry. This
effect was maintained over a period of at least eight days without activating an unfolded protein response (UPR). Moreover,
the ER retention of p75NTR resulted in downregulation of mRNA levels of the anti-apoptotic protein Bcl-xL as well as in
strong inhibition of NGF-induced neurite outgrowth in PC12 cells.
Conclusion: The ER retained intrabody SH325-G7-KDEL not only induces phenotypic knockdown of this p75NTR but also
p75NTR-associated cellular responses in PC12 cells.
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Introduction
Neurotrophins have been known as the critical factors in
development and functioning of the nervous system [1]. It has
been demonstrated that neurotrophins exert their effects such as
proliferation, differentiation, survival and apoptosis by binding to
two types of surface receptors, the tyrosine kinase receptor (Trk)
family and the p75 neurotrophin receptor (p75NTR). In contrast
to Trk receptors, p75NTR binds to all neurotrophins without
selectivity. P75NTR normally collaborate with many different
protein partners [2]. Although p75NTR is the first neurotrophin
receptor identified, its precise physiological role is still conflicting
to date [3]. P75NTR is usually considered as a proapoptotic
receptor; however, it has also been found that p75NTR enhanced
the survival of neurons in the presence of Trk receptors [4]. A
survival response was also reported in rat Schwann cells, in which
nuclear factor kappa B (NFkB) was activated via NGF-induced
p75NTR signaling pathway [5]. It has been reported that Trk
receptors are essential for neurite outgrowth and p75NTR was
shown to negatively alter dendrite complexity and spine density in
hippocampal pyramidal neurons [6]. Nevertheless, it has also been
demonstrated that applying an anti-p75NTR antibody, MC192,
can inhibit NGF-dependent neurite extensions of hippocampal
neurons [7] and sensory neurons [8].
Many approaches have been applied to investigate p75NTR in
vivo and in vitro, such as gene-targeted knockout mice, antisense
RNA, and siRNA, but none of them performs modulations at the
post-translational level. Endoplasmic reticulum (ER) retained
intrabodies can specifically trap target proteins within the ER
based on an ER retention signal at the C-terminus (for review see
Bo ¨ldicke, 2007) [9]. This technology takes advantage of the
naturally occurring mechanism of ER-resident protein retro-
translocation in mammalian cells. KDEL, a conserved carboxy-
terminal tetrapeptide, is the most common ER retention signal
used for this purpose. In contrast to gene-silencing knockdown
techniques, ER retained intrabodies offer the possibility to
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Besides the high affinity and specificity provided by an antibody
moiety, ER retained intrabodies are expressed very stably in
mammalian cells compared to siRNAs [10] or aptamers [11]. The
functional knockdown of vascular cell adhesion molecule 1
(VCAM-1) has been recently demonstrated by using an intrabody
[12].
In this study, recombinant antibodies specific to p75NTR were
selected by antibody phage display technology (for review see
Du ¨bel et al. 2010) [13]. Based on screening high diversity ‘single-
pot’ antibody gene libraries, monoclonal antibody fragments with
high specificities and affinities can be selected rapidly [14,15,16].
The whole screening procedure, called panning, is done
completely in vitro and offers speed and properties difficult to
obtain with hybridoma technique [17,18]. For detailed analysis of
intrabody-induced knockdown, we constructed a novel bicistronic
knockdown vector, encoding both the intrabody and farnesylated
fluorescent reporter protein (Fig. 1). The effect of anti-p75NTR
intrabody production on stress response, Bcl-xL mRNA expres-
sion, and NGF-induced neurite outgrowth of PC12 cells were
analyzed.
Results
Selection of recombinant scFvs against the extracellular
domain of p75NTR by antibody phage display
Antibody phage display technology was applied to isolate scFvs
against the extracellular domain of p75NTR. The antigen
p75NTRex-Fc protein was prepared by fusing mouse p75NTR
extracellular domain DNA (a kind gift from RZPD, Germany)
with the human IgG1 Fc domain gene. After transient production
in HEK 293T cells, the p75NTRex-Fc fusion protein was purified
by protein A affinity chromatography before being used for
panning with naı ¨ve human antibody gene libraries HAL4 (Kappa)
and HAL7 (Lambda) [16]. In order to avoid the selection of scFvs
against human IgG1 Fc portion, N protein standard SL (Dade
Benring, Germany), a human serum standard containing human
IgG, was used as soluble competitor during the panning
procedure. After three rounds of panning and selection, individual
clones were isolated. Soluble monoclonal scFvs were produced in
E. coli cultured in microtiter plates [19] and assessed for their
binding abilities to the immobilized p75NTRex-Fc fusion protein
by ELISA (data not shown). Three unique p75NTR-specific scFvs
(SH325-A11, SH325-B6, and SH325-G7) were finally identified
after DNA sequencing. Their sequences were analyzed based on
the integrative database of germline variable genes from the
immunoglobulin loci of human (VBASE2, http://www.vbase2.
org/) [20]. The VH of all three antibodies were derived from a
VH3 germline gene. The light chains were of lambda type in all
three cases with the V genes from different germline genes
(Table 1).
Characterization of the p75NTR-specific scFvs
The p75NTR-specific scFvs were produced by periplasmic
expression in E. coli and purified by immobilized metal affinity
chromatography (IMAC). The binding kinetics of the p75NTR-
specific scFvs to the solid phase immobilized p75NTRex-Fc fusion
protein was determined by surface plasmon resonance (SPR)
spectroscopy (Biacore). Recombinant rat TrkAex-Fc fusion protein
was used as a negative control. The measured affinities were in a
low nanomolar range (3.9–39 nM, see Table 2).
Specificity of the p75NTR-specific scFvs was assayed by antigen
ELISA to check for cross-reactivity with other related neuronal
receptors which may have antagonistic functions to p75NTR [3].
As shown in Figure 2A, all scFvs specifically bound to the
p75NTRex-Fc fusion protein but not to other Fc fusion proteins as
rat TrkA (TrkAex-Fc), rat TrkB (TrkBex-Fc), mouse Nogo
receptor (NgRex-Fc), mouse and human amyloid precursor
protein (APPex-Fc). The binding of these scFvs to native antigen
on living cells was verified by flow cytometric analysis (Fig. 2B).
Since high homology is shown between mouse and rat p75NTR
[21], rat pheochromocytoma PC12 cells which are neuron-like
cells endogenously expressing p75NTR was used [22]. The
Figure 1. Schematic representation of the bicistronic knockdown vector. CMV: cytomegalovirus immediate-early promoter; VH: variable
domain of heavy chain; VL: variable domain of light chain; KDEL: C-terminal ER retention signal; IRES: internal ribosomal entry site; EGFP-F:
farnesylated enhanced green fluorescent protein; PolyA: BGH polyadenylation sequence.
doi:10.1371/journal.pone.0030684.g001
Table 2. Binding kinetics of the p75NTR-specific scFv as
determined by surface plasmon resonance.
Ka (1/M?s) kd (1/s) Rmax (RU) X
2 KD (M)
SH325-A11 2.44610
5 1.57610
23 156 2.31 6.5610
29
SH325-B6 4.45610
5 1.74610
23 162 4.43 3.9610
29
SH325-G7 1.08610
5 4.22610
23 180 0.24 3.9610
28
doi:10.1371/journal.pone.0030684.t002
Table 1. P75NTR-specific scFvs isolated by phage display.
Antibody VH VL
clone V D J V J
SH325-A11 IGHV3-
23*01
IGHD6-
13*01
IGHJ4*02 IGLV6 IGLJ3*02
SH325-B6 IGHV3 IGHD6-
19*01
IGHJ4*02 IGLV3-
21*02
IGLJ3*01
SH325-G7 IGHV3 IGHD2-
15*01
IGHJ3*02 IGLV1-
44*01
IGLJ3*02
The names of gene segments are as given in VBASE2. V: variable gene; D:
diversity gene segment; J: joining gene segment.
doi:10.1371/journal.pone.0030684.t001
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PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e30684Figure 2. Characteration of the p75NTR-specific antibodies. (A) Antigen binding ELISA. 100 ng of mouse p75NTRex-Fc (shown in dark blue),
rat TrkAex-Fc, rat TrkBex-Fc, mouse NgRex-Fc, mouse or human APPex-Fc, N protein SL standard or BSA were immobilized in the plate for each well.
250 ng of each scFv was added after the antigen-coated plates were blocked with FCS for 1.5 hr. Bound scFvs were detected using anti myc-tag mAb
(1:500) and goat anti-mouse IgG HRP conjugated (1:5,000). (B) The scFvs specifically recognize native p75NTR on PC12 cell surfaces. PC12 or HEK293T
cells were stained with 250 ng of the p75NTR-specific scFvs (SH325-A11, SH325-B6, SH325-G7). Bound scFvs were detected by mouse anti-His6 mAb
(1:100) followed by goat anti-mouse IgG F(ab9)
2 fragment APC conjugated (1:200). The p75NTR surface expression on PC12 cells was determined by
staining PC12 or HEK293T cells with mouse anti-p75NTR mAb (MLR2, 1:200) followed by goat anti-mouse IgG F(ab9)
2 fragment APC conjugated
(1:200). The blue histograms represent the mouse anti-p75NTR mAb (MLR2) or the p75NTR-specific scFvs staining PC12 cells (upper row) and HEK
293T cells (lower row). The white histograms represent the controls stained with goat anti-mouse IgG F(ab9)
2 fragment APC conjugated alone (MLR2
line) or aphOx scFv (other lines) followed by mouse anti-His6 mAb and goat anti-mouse IgG F(ab9)
2 fragment APC conjugated. (C) Detection of
denatured antigen (p75NTRex-mFc) by the p75NTR-specific recombinant antibodies in immunoblot. 250 ng of p75NTRex-mFc was denatured and
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using the commercial mouse anti-p75NTR mAb (MLR2). HEK
293T cells were used as p75NTR negative control cells. A scFv
against the hapten 2-phenyloxazoline-5-one [23] was used as the
negative control antibody. All the p75NTR-specific scFvs
specifically bound to the PC12 cells, while none of them showed
binding to the HEK 293T cells.
The interaction between the p75NTR-specific recombinant
antibodies and p75NTR extracellular domain was also analyzed
by Western blotting (Fig. 2C). 250 ng of p75NTRex-mFc,
prepared by fusing the extracellular domain DNA of mouse
p75NTR with mouse IgG1 Fc domain gene, was denatured and
blotted on a PVDF membrane. The denatured antigen was
incubated with three p75NTR-specific scFv human Fc fusion
recombinant antibodies (SH325-A11-Fc, SH325-B6-Fc, and
SH325-G7-Fc), respectively. Compared to SH325-G7-Fc,
SH325-A11-Fc and SH325-B6-Fc showed much weaker signals
in immunoblot for detecting the denatured p75NTR.
Mouse anti-p75NTR mAb (MLR2) and the p75NTR-
specific scFvs bind to different, non-overlapping
epitopes
To be able to detect changes in surface expression of p75NTR
in the presence of intrabodies, it must be assured that the
intrabodies do not interfere with the binding of the detection
antibodies. To check this, a consecutive competition ELISA was
performed with the p75NTR-specific scFvs and the mouse anti-
p75NTR mAb (MLR2), which was to be used to analyze the
p75NTR surface expression (Fig. 3). Signal intensities of three
p75NTR-specific scFvs increased in a concentration dependent
way (Fig. 3 red lines). No significant change in signal intensities
was observed for the mouse anti-p75NTR mAb (MLR2) in the
presence of the different scFv concentrations (Fig. 3, blue lines).
This indicates that the binding of mouse anti-p75NTR mAb
(MLR2) to p75NTR was not inhibited by the p75NTR-specific
scFvs.
Knockdown of p75NTR surface expression in PC12 cells
by p75NTR-specific ER retained intrabodies
The gene encoding the p75NTR-specific scFvs were subcloned
into the bicistronic knockdown vector to generate ER retained
intrabodies (SH325-A11-KDEL, SH325-B6-KDEL and SH325-
G7-KDEL). This knockdown vector adds a C-terminal ER
retention motif KDEL to the scFv fragments. The first cistron
with the ER retained intrabody is controlled by a CMV promoter,
while a farnesylated form of EGFP (EGFP-F) was driven as second
cistron by a mutant EMCV IRES element in cap-independent
mechanism [24]. Because the ER retained intrabody and EGFP-F
blotted on a PVDF membrane. 1 mg of each p75NTR-specific recombinant antibody was used to stain the membrane for 1.5 hr. The bound antibodies
were detected by goat anti-human IgG Fc antiserum AP conjugated (1:2,000) for 1 hr at RT.
doi:10.1371/journal.pone.0030684.g002
Figure 3. Competition ELISA for epitope overlapping. 100 ng of mouse p75NTRex-Fc fusion protein was immobilized in plates for each well.
Serial diluted p75NTR-specific scFvs were added and incubated for 1.5 hr at 37uC. After 36washing with PBST, the plates were incubated with mouse
anti-p75NTR mAb (MLR2, 1:5,000) for 1.5 hr at 37uC. The plate was washed 36 with PBST. The scFvs and mouse anti-p75NTR mAb (MLR2) were
detected by mouse anti-His5 mAb HRP conjugated (1:5,000) and goat anti-mouse IgG HRP conjugated (1:5,000) in corresponding plates.
doi:10.1371/journal.pone.0030684.g003
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body-expressing cells can be easily detected by flow cytometry and
fluorescence microscopy. Furthermore, EGFP-F is bound to the
inner plasma membrane of cells even after fixation; it thereby
facilitates morphological studies, especially of neurons. First, we
analyzed the p75NTR surface expression in PC12 cells transiently
transfected with the bicistronic knockdown vectors. As a control,
the ER retained intrabody aphOx-KDEL was used. Four days
after transfection, the p75NTR surface expression in PC12 cells
was analyzed by flow cytometry (Fig. 4). The untransfected PC12
cells showed p75NTR expression on their cell surfaces (Fig. 4B).
Cells transfected with the ER retained intrabodies were identified
by co-expression of EGFP-F reporter gene. If the p75NTR
surface expression is downregulated by the ER retained
intrabodies, the cell population is expected to be shifted from
the upper right quadrant to the lower right quadrant. High levels
of p75NTR were expressed on the surfaces of the cells transfected
with aphOx-KDEL control construct (Fig. 4D). No considerable
reduction of the p75NTR surface expression was detected in the
SH325-A11-KDEL transfected cells (Fig. 4F). In the cells
transfected with SH325-B6-KDEL, a moderate decrease of
p75NTR surface expression was measured (Fig. 4H). P75NTR
surface translocation was remarkably inhibited in the SH325-G7-
KDEL transfected cells, resulting in a shift of the transfected cell
population from the FL4
+/FL1
+ to the FL4
2/FL1
+ quadrant
(Fig. 4J). Unspecific binding from the detection antibody was
excluded by using negative controls stained with the secondary
antibody alone (Fig. 4A, 4C, 4E, 4G, and 4I). An overlay analysis
was performed between the cells expressing the p75NTR-specific
ER retained intrabodies and those expressing the control
construct (Fig. 4K). By comparing the mean fluorescence
intensities between the cells expressing the p75NTR-specific ER
retained intrabody SH325-G7-KDEL and the cells expressing the
control aphOx-KDEL, the efficiency of knockdown p75NTR
surface expression was 56%.
P75NTR surface expression was downregulated by the
p75NTR-specific ER retained intrabodies in NSC19 cells
The effect of p75NTR-specific ER retained intrabodies was also
analyzed in mouse NSC19 cells [25]. Four days after transfection
with the ER retained intrabodies, the NSC19 cells were stained for
p75NTR and subjected to flow cytometric analysis. The efficiency
of knockdown p75NTR surface expression was calculated as
described above. The effects of the three p75NTR-specific ER
retained intrabodies were comparable to the effects observed in
PC12 cells (Fig. 5). Again, the most distinctive effect was seen with
SH325-G7-KDEL (56% reduction). SH325-A11-KDEL or
SH325-B6-KDEL transfected cells showed 29% or 42% reduction
on the p75NTR surface expression, respectively.
Intracellular expression levels of the p75NTR-specific ER
retained intrabodies
To figure out the reason for the difference among the
knockdown efficiencies, the amount of intracellular ER retained
intrabodies was analyzed after transient transfection of knockdown
vectors encoding the p75NTR-specific ER retained intrabodies
into PC12 cells. Transfection efficiencies were determined in
different experiments in flow cytometry. Four days after
transfection, 2610
6 cells from each sample were lysed in 200 mL
of lysis buffer. The intracellular expression of the p75NTR-specific
ER retained intrabodies was evaluated by immunoblotting and
bands corresponding to the calculated molecular masses were
identified (Fig. 6A). A negative control resulted from the cell
extracts of untransfected PC12 cells. The signal intensities were
analyzed by ImageJ software. The intracellular expression level of
SH325-G7-KDEL was approximately 2–3 times more than those
of SH325-A11-KDEL and SH325-B6-KDEL in transiently
transfected PC12 cells (Fig. 6B).
P75NTR surface expression was suppressed by the
p75NTR-specific ER retained intrabody for at least 8 days
in PC12 cells
The kinetics of the p75NTR-specific knockdown by ER
retained intrabodies after transiently transfection in PC12 cells
was analyzed over 8 days using the construct of SH325-G7-KDEL
(Fig. 7). The effect of p75NTR-specific ER retained intrabody
progressively increased from 2 to 4 days after transfection with a
maximal knockdown (56% reduction) at day 4 post-transfection.
Afterwards, the suppression of p75NTR surface expression slightly
decreased to 39% after 8 days.
P75NTR-specific ER retained intrabody expression does
not activate the unfolded protein response (UPR) in PC12
cells
To assess the stress imposed to the cells by the of the specific
ER retained intrabody productions, UPR was analyzed during
the knockdown process up to 8 days. ER resident 94 kDa
glucose-regulated protein (GRP94) was used as the reporter
protein for ER stress response. Its expression is upregulated due
to ER stress [26]. PC12 cells were transiently transfected with
SH325-G7-KDEL. Cells from different time points (2–8 days)
were sorted by BD FACSAria
TM II based on EGFP-F
fluorescence to eliminate nontransfected cells. Negative and
positive controls were prepared by treating PC12 cells for 24 hr
with DMSO alone or 20 mg/mL of tunicamycin, respectively.
Tunicamycin is known as an UPR stimulus because it inhibits N-
linked glycosylation [27] and influences glycoprotein membrane
transport [28]. The expression levels of GRP94 were evaluated
by immunoblotting (Fig. 8). Glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) served as an internal reference to ensure
equal total protein loading and was detected on the same
membrane. Intrabody production did not lead to any detectable
GRP94 upregulation compared to the DMSO treated negative
control. In contrast, tunicamycin treated cells showed a
considerable increase of GRP94 expression.
Downregulation of p75NTR surface expression by the ER
retained intrabody reduces Bcl-xL mRNA expression in
PC12 cells
A previous study reported that constitutive Bcl-xL expression is
related to p75NTR signaling in PC12 cells [29]. In order to
investigate the impact of the downregualtion of p75NTR surface
expression by the ER retained intrabody, Bcl-xL mRNA
expression was evaluated by real-time qRT-PCR. Six days after
transfection, the Bcl-xL mRNA expression of the cells treated
with SH325-G7-KDEL construct was only half as high as that of
the untransfected PC12 cells (Fig. 9). In contrast, there is no
significant difference in Bcl-xL mRNA expression between the
cells transfected with control constructs and untransfected cells.
Besides aphOx-KDEL, another control construct was SH325-G7
which lacks the ER retention sequence KDEL. It is not capable
to retain p75NTR within the ER and did not influence Bcl-xL
expression. The results suggest that the reduction of Bcl-xL
mRNA expression was caused by the suppression of p75NTR
surface expression.
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induced neurite outgrowth in PC12 cells
Further investigation was performed in PC12 cells to study the
influence of p75NTR surface knockdown on NGF-induced neurite
outgrowth. Cells were transfected with SH325-G7-KDEL, or the
controls SH325-G7 or aphOx-KDEL. Two days after transfec-
tion, the cells were induced with 200 ng/mL NGF for four days.
Photographs of transfected cells, as indicated by EGFP-F
expression, were collected from each sample under the microscope
(Fig. 10). Approximately 100 transfected cells were counted from
each sample. The transfection of PC12 cells with SH325-G7-
KDEL strongly inhibited the NGF-induced neurite outgrowth
(Fig. 10C). In contrast, the PC12 cells transfected with the controls
SH325-G7 and aphOx-KDEL tended to extend long neurites in
the presence of NGF (Fig. 10A, 10B). Quantification revealed that
50% of the cells transfected with the control constructs extended
neurites after NGF treatment, whereas only 18% extended
neurites after transfected with the SH325-G7-KDEL construct
(Fig. 10D).
Discussion
P75NTR belongs to the tumor necrosis factor receptor (TNFR)
superfamily and plays a critical role in almost all aspects of the
function of vertebrate neurons. P75NTR has been reported to
affect neuronal survival, apoptosis, neurogensis, synaptic plasticity,
and long-term depression in ligand-dependent and -independent
mechanisms [30,31,32,33]. P75NTR is also known to be linked to
many human diseases, including schizophrenia, cerebral edema,
neural crest tumors, stroke, Alzheimer’s disease and several
hereditary neurodegenerative disorders like ataxia-talangectasia
and spinocerebella ataxias [34]. So far, most functional studies on
p75NTR focused at the genetic level. Gene knockout p75NTR
2/2
mice are important animal models to study the in vivo role of
p75NTR. However, gene-targeted knockout is a time-consuming
work on the one hand, and alternative splicing products, on the
other hand, have been reported in both p75NTR
exonIII and
p75NTR
exonIV knockout phenotypes [35,36]. These alternative
splicing products contain the intact transmembrane and intracel-
lular domain of p75NTR that are suggested to have proapoptotic
effects rather than to be only splicing products without any function
[37,38]. RNAi is another promising technique which was frequently
used to downregulate p75NTR expression. But RNAi induces
unexpected off-target effects on gene expression and the possibility
of interferon response induction in cells, which nonspecifically
suppresses protein translation [10,39,40,41]. In addition, the
general short half-life of siRNA prevents long period studies or
therapeutic application [42]. In contrast, ER retained intrabody
knockdown technology has not only the advantages of an antibody
like high specificity, affinity and stability, but it can also efficiently
inhibit the translocation of specific secretory or surface molecules
from the ER to the cell surface [9,12,43]. In this study, we present a
phenotypic knockdown of p75NTR at the post-translationallevel by
using ER retained intrabodies for the first time.
Three scFvs to the extracellular domain of mouse and rat
p75NTR, SH325-A11, SH325-B6 and SH325-G7, with high
monovalent affinities (3.9 to 39 nM) were selected from the naı ¨ve
human antibody gene libraries HAL4/7 [16] and tested for
intrabody-induced knockdowns. The calculated knockdown never
was 100%, but this may be explained at least in part by the overall
very low initial expression level of p75NTR on the cells, not allowing
baselineseparation of thehistograms. Interestingly,themostefficient
downregulation of surface p75NTR in PC12 and NSC19 cells was
achieved with the construct SH325-G7, which has the lowest affinity
among the three isolated p75NTR-specific scFvs. In transiently
transfected PC12 cells, 2–3 times more SH325-G7-KDEL was
produced compared to SH325-A11-KDEL and SH325-B6-KDEL;
therefore, the intrabody expression level seems to be one of the
Figure 4. Knockdown of p75NTR surface expression in PC12 cells by the p75NTR-specific ER retained intrabodies. PC12 cells were
transiently transfected with the p75NTR-specific ER retained intrabodies or aphOx-KDEL. Four days after transfection, the p75NTR surface expressions
were determined with mouse anti-p75NTR mAb (MLR2, 1:200) followed by goat anti-mouse IgG F(ab9)
2 fragment APC conjugated (1:200, B, D, F, H,
and J). Cells stained with secondary antibody alone were served as control (A, C, E, G, and I). Overlay analysis for the p75NTR surface expression is
shown in PC12 cells (K). The blue histograms represent the p75NTR surface expression of the PC12 cells expressing the p75NTR-specific ER retained
intrabodies. The white histograms represent the p75NTR surface expression of the PC12 cells expressing the control aphOx-KDEL. The efficiency of
knockdown p75NTR surface expression is indicated in percent. The picture of SH325-G7-KDEL is also shown in Figure 7 as 4 day time point result.
doi:10.1371/journal.pone.0030684.g004
Figure 5. Knockdown of p75NTR surface expression in NSC19 cells by the p75NTR-specific ER retained intrabodies. NSC19 cells were
transiently transfected with the p75NTR-specific ER retained intrabodies or the control aphOx-KDEL. Four days after transfection, the p75NTR surface
expressions were determined with mouse anti-p75NTR mAb (MLR2, 1:200) followed by goat anti-mouse IgG F(ab9)
2 fragment APC conjugated (1:200).
The blue histograms represent the p75NTR surface expressions of the NSC19 cells expressing the p75NTR-specific ER retained intrabodies. The white
histograms represent the p75NTR surface expressions of the NSC19 cells expressing the control aphOx-KDEL. The efficiency of knockdown p75NTR
surface expression is indicated in percent.
doi:10.1371/journal.pone.0030684.g005
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PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30684Figure 6. Intracellular expression levels of the p75NTR-specific ER retained intrabodies in PC12 cells. (A) Quantitative determination by
immunoblotting. PC12 cells were transiently transfected with the constructs encoding the p75NTR-specific ER retained intrabodies. Four days after
transfection, cell extracts were prepared and separated by SDS-PAGE. After immunoblotting, the membrane was incubated with mouse anti-His5
mAb (1:2,000) for 1 hr at RT and followed by goat anti-mouse IgG AP conjugated (1:5,000) for 1 hr at RT. The control resulted from the cell extracts of
untransfected PC12 cells. Intracellular expression levels of the p75NTR-specfic ER-intrabodies were calculated according to the scFv standard. (B)
Quantification of intrabody production by densitometric analysis of gels as shown in (A). The error bars represent standard deviations calculated from
three independent transfection experiments.
doi:10.1371/journal.pone.0030684.g006
Figure 7. Kinetics of the p75NTR knockdown effect in PC12 cells. PC12 cells were transiently transfected with SH325-G7-KDEL or the control
aphOx-KDEL and harvested at different time points. The p75NTR surface expression levels were determined with mouse anti-p75NTR mAb (MLR2,
1:200) followed by goat anti-mouse IgG F(ab9)
2 fragment APC conjugated (1:200). The blue histograms represent the p75NTR surface expressions of
the PC12 cells expressing SH325-G7-KDEL. The white histograms represent the p75NTR surface expressions of the PC12 cells expressing aphOx-KDEL.
The efficiency of knockdown p75NTR surface expression is indicated in percent.
doi:10.1371/journal.pone.0030684.g007
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Although increased affinity or avidity also seems important to
improve the effect of ER retained intrabodies, higher affinities of the
antibodies did surprisingly not increase knockdown efficiency in this
study.ItshouldnottobeforgottenthatdifferentscFvsmayrecognize
different p75NTR epitopes which are not accessible in the same way
in the ER, or that folding may not be completed [44]. In respect of
the latter, we observed on the immunoblot analysis that SH325-G7
was the best binder for denatured (i.e. unfolded) p75NTR.
Therefore, it is possible that antibodies with high affinity to linear
epitopes may mediate higher intrabody-induced knockdown effi-
ciency. If so, this effect can be expected to strongly depend on the
individual antigen, but is surely worth further evaluation in future
intrabody studies.
The p75NTR downregulation by the intrabody SH325-G7-
KDEL construct was time dependent and long lasting, with a
maximum at day 4 post-transfection and remaining relatively
stable for at least 8 days. UPR, a stress response described to be
caused by strong protein overexpression in the ER [45,46], was
not observed during this time period. Since UPR was activated
neither by the transient transfection procedure nor by the
intrabody production, it can be assumed that general protein
synthesis was not halted and the ER stress-induced apoptosis was
not initiated in the cells expressing the ER retained intrabody, and
unspecific off-target effects seem to be negligible [47,48].
It has been demonstrated that p75NTR can mediate proapop-
totic or prosurvival signaling depending on the molecular context
[3,49,50]. In the present study, we observed that the Bcl-xL
mRNA expression was reduced by downregulation of p75NTR
cell surface expression. This result is in agreement with a previous
study, where constitutive Bcl-xL mRNA expression level was
decreased in PC12 cells after blocking cell surface p75NTR by an
anti-p75NTR antibody [29]. It might be caused by the p75NTR-
dependent PI3-kinase/Akt survival pathway activation [51], which
is independent to the TrkA signaling and has been proved to
upregulate Bcl-x gene expression [52]. These results suggest that
p75NTR surface expression is required for constitutive Bcl-xL
expression and may provide support in survival signaling.
Furthermore, we found that the neurite outgrowths were
substantially repressed by inhibiting p75NTR surface expression
in PC12 cell. This repression was not a result of transfection
procedures or the additional overexpression of a scFv fragment,
since it was not observed with the control antibodies. It is known
that p75NTR is heavily colocalized with TrkA on the cell surface
and enhances the affinity and selectivity of TrkA for NGF binding
[53,54]. The direct association or indirect communication
between p75NTR and TrkA contributes to the downstream
signaling [55,56]. These findings indicate that p75NTR is essential
to improve TrkA signaling activation. Moreover, p75NTR delays
TrkA internalization and degradation upon NGF treatment and
thereby facilitates the prolongation of cell surface TrkA signaling
[57]. A previous study reported that TrkA alone was sufficient for
NGF-induced neurite outgrowth in PC12 cells [58]. In contrast to
that, our observations suggest that p75NTR plays a subtle but
critical role in NGF-induced PC12 differentiation. This is
consistent with a previous finding in which p75NTR has been
shown to be essential for NGF-induced growth arrest by activating
Akt in PC84 cells, a mutant p75NTR-deficient PC12 cell line [59].
It was found that PC84 cells continued to proliferate instead of
differentiating in the presence of NGF. Intrabodies provide a
valuable tool for future studies of this receptor at the posttrans-
lational level. As the number of recombinant antibodies generated
from large consortia aiming to cover entire proteome is rapidly
increasing [13,18,60], their possible use to analyze their antigens
by an intrabody strategy may significantly contribute to the
functional analysis of proteins with yet unknown roles.
Materials and Methods
Cell cultures and transfections
Human embryonic kidney (HEK) 293T cells (ATCC) were
cultured in Dulbecco modified Eagle medium (DMEM)/high
glucose (4.5 g/L) and L-glutamine (2 mM) supplemented with 8%
(v/v) fetal calf serum (FCS), and 1% (v/v) penicillin/streptomycin
(PAA, Germany) and cultivated at 37uC in a 7% CO2 incubator.
RatpheochromocytomaPC12cells(DSMZ)wereculturedinRPMI
1640/L-glutamine (2 mM) supplemented with 10% horse serum
(HS) and 5% (v/v) FCS (PAA, Germany). Mouse neuroblastoma x
mouse spinal cord hybrid NSC19cells (a kind gift from Prof. Brigitte
M.Jockusch,ZoologicalInstitute,Technische Universita ¨t Braunsch-
weig, Germany) were maintained in DMEM/high glucose (4.5 g/L)
Figure 8. Stress response (UPR) in cells transfected with
intrabody construct SH325-G7-KDEL. The SH325-G7-KDEL trans-
fected PC12 cells from different time points (2–8 days) were sorted
based on the EGFP-F fluorescence. Cells treated with 20 mg/mL of
tunicamycin (Tun) or solvent alone (DMSO) were used as the positive or
negative control, respectively. Cell extracts were prepared and blotted
on a PVDF membrane. The membrane was incubated with rabbit anti-
GRP94 (1:1,000) and rabbit anti-GAPDH (1:5,000) for 1 hr at RT. After 36
washing with PBST, the membrane was subsequently incubated with
goat anti-rabbit IgG AP conjugated antibody (1:5,000) for 1 hr at RT.
GAPDH served as an internal control to ensure equal protein loading.
doi:10.1371/journal.pone.0030684.g008
Figure 9. Bcl-xL mRNA expression correlates with p75NTR
surface expression knockdown. PC12 cells were transfected with
the constructs of SH325-G7-KDLE, or the negative controls SH325-G7 or
aphOx-KDEL. Six days after transfection, total RNA was extracted. The
Bcl-xL mRNA expression, normalized to the housekeeping gene b-actin,
was determined by real-time qRT-PCR. These results were then
compared to the normalized Bcl-xL expression in untransfected PC12
cells. The error bars represent standard deviations from two indepen-
dent experiments.
doi:10.1371/journal.pone.0030684.g009
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and NSC19 cells were cultivated at 37uC in a 5% CO2 incubator.
Cellswerepassaged inevery 2–3 days in1:10 (forHEK 293T) or1:2
(for PC12 and NSC19) dilutions.
HEK293T cells were transfected by HEKFectin (Bio-Rad,
Germany), while PC12 and NSC19 cells were transfected by
NeuroMag (OzBiosciences, France) according to the supplier’s
instructions or by electroporation (Bio-Rad Gene Pulser Xcell
TM,
Germany). For electroporation, 20 mg of endotoxin-free Midi-Prep
prepared DNA was mixed with 2.4610
6 PC12 cells in 400 mLo f
RPMI 1640 medium and transferred into a 0.4 cm electrode
cuvette (Bio-Rad, Germany). Single pulse (300 v, 950 mF) was
applied at RT. After electroporation, cells were immediately
replated with culture medium in poly-L-lysine pre-coated culture
plates. Transfection efficiency was more than 70% as determined
by flow cytometry after 24 hr.
Plasmid construction
Expression vector for antigen production in HEK 293T cells:
The extracellular domain cDNA of mouse p75NTR was
amplified from RZPD (German Science Centre for Genome
Research, Germany) clone IRAVp968B1065D6 by PCR using the
primer pair of 59-TGC CAT GGC AAA GGA GAC ATG TTC
CAC AGG CAT GT-39 and 59-AGA CGC GGC CGC AGG
AAT GAG GTT GTC AGC GGT GCC T-39. A mouse
p75NTRex-Fc fusion construct was generated by cloning the
PCR product via NcoI and NotI into pCMV-hIgG1-Fc-XP [16], a
modified pCMV vector containing the human IgG1 Fc domain.
The human antibody Vk3 (hVk3S) subfamily signal sequence and
the mouse antibody heavy chain VH3 (mVH3S) subfamily signal
sequence containing a synthetic intron proceeded secretion of the
mouse p75NTRex-Fc fusion protein in HEK 293T cells. The
resulting expression vector for mouse p75NTRex-Fc fusion
protein was named pCMV-mp75NTRex-Fc.
Expression vectors for scFv productions in E. coli:
Primers 59-GCC TAC GGC AGC CGC TGG-39 and 59-GAT
CCT CTT CTG AGA TGA G-39 were used to amplify the scFv
cDNA sequences from the phage display vector by PCR. The E.
coli expression vectors pOPE101-SH325-A11, pOPE101-SH325-
B6, and pOPE101-SH325-G7 were generated by cloning the scFv
cDNA sequences into E. coli expression vector pOPE101-XP [61]
via NcoI/NotI.
Knockdown vectors:
The bicistronic knockdown vectors encode p75NTR-specific
ER retained intrabodies and a farnesylated EGFP (EGFP-F) as a
reporter gene directed by a modified EMCV-R IRES element
(Fig. 1). The sequence containing His6-tag, ER retention sequence
KDEL and cDNA of encephalomyocarditis virus (EMCV) internal
ribosomal entry site (IRES) element [24] in order were subcloned
into the knockdown vector via NotI/NcoI. The cDNA sequence of
EGFP-F [6] were subcloned into the knockdown vector via NcoI/
XbaI. Three p75NTR-specific scFvs were amplified by PCR using
the reverse primer 59-ATG TGC GGC CGC AGA GGA CGG
T-39 with three corresponding forward primers 59-GGC CGC
GCG CAC TCC GAG GTG CAG CTG TTG GAG ACC GGG
GGA-39,5 9-GGC CGC GCG CAC TCC CAG GTG CAG CTG
GTG CAG TCT GGG GGA-39,5 9-GGC CGC GCG CAC
TCC GAG GTG CAG CTG GTG CAG TCT GGG GGA-39.
The DNA encoding the scFv against the hapten 2-phenyloxazo-
line-5-one (phOx) was amplified by PCR using 59-ACA GGC
Figure 10. Effect of intrabody expression on the NGF-induced differentiation of PC12 cells. (A) PC12 cells transfected with the aphOx-
KDEL construct. (B) PC12 cells transfected with the SH325-G7 construct. (C) PC12 cells transfected with SH325-G7-KDEL construct. (D) Percentage of
differentiated PC12 cells in the cells transfected with different constructs (about 100 cells counted for each sample).
doi:10.1371/journal.pone.0030684.g010
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and 59-CCA GGA GTT CAG GTG CTG-39. The resulting PCR
products were digested with BssHII and NotI and ligated into the
knockdown vectors.
Antigen production for antibody phage display
One day before transfection, HEK293T cells were seeded onto
a 10-cm petri dish using DMEM/high glucose supplemented with
1% (v/v) penicillin/streptomycin and 8% (v/v) FCS. HEK293T
cells were transfected with the plasmid of pCMV-mp75NTRex-
Fc. Twenty four hours after transfection, the medium was changed
to DMEM/high glucose supplemented with 1% (v/v) penicillin/
streptomycin and 4% (v/v) bovine low IgG level FCS (PAA,
Germany). Expressed p75NTRex-Fc fusion protein was collected
in the supernatant every 2 days for 14 days and purified by affinity
chromatography using a HiTrap
TM 1 mL protein A HP column
on an A ¨ktaPrime system (GE Healthcare, Sweden) according to
manufacturer’s instructions.
Selection of recombinant antibodies against the p75NTR
extracellular domain
ScFvs against the p75NTR extracellular domain were selected
from the naı ¨ve human antibody gene library HAL4 (Kappa) and
HAL7 (Lambda) [16]. The library was packaged using Hyperph-
age [62,63] to allow polyvalent display in the first panning round
and mixed before panning. The panning and selection was
performed as described previously [64]. The p75NTRex-Fc fusion
protein was used panning antigen. Human IgG1 Fc (N Protein
standard SL, DADE Behring, Germany) was used for preincuba-
tion of the library and for competition during the panning
procedure to omit the selection of binders specific to the human
IgG1 Fc domain.
Production and purification of soluble p75NTR specific
scFvs
Soluble p75NTR-specific scFvs were produced in shaking flasks
using the E. coli strain XL1-Blue MRF’ (Stratagene, Netherland)
transfected with the pOPE101 constructs according to the
procedure previously described [65]. Immobilized metal affinity
chromatography (IMAC) was used for soluble scFv purifications
from periplasmic extracts. Chromatography was performed using
0.5 mL Chelating Sepharose
TM Fast Flow (GE Healthcare,
Germany) according to the manufacturer’s instruction.
Antigen ELISA
A BD Falcon
TM 96-well flexible plate (BD, USA) was coated
with 100 ng of p75NTRex-Fc fusion protein or controls in 100 mL
of PBS per well at 4uC overnight. The coated plate was blocked
with 100 mL of FCS per well for 1.5 hr at 37uC and then washed
36with PBST. The plate was then incubated with 250 ng of the
p75NTR-specific scFvs for 1.5 hr at 37uC. After 36washing with
PBST, these scFvs were detected by anti myc-tag mAb
(hybridoma, 1:500) and goat anti-mouse IgG (Fab specific)
antiserum conjugated with horseradish peroxidase (HRP)
(1:5,000, Sigma, USA). Binding was visualized with TMB
(3,39,5,59-tetramethylbenzidine) substrate and stopped by 100 mL
of 1 N sulphuric acid per well. The absorbance at 450 nm with
subtracting the 620 nm reference was measured by a SUNRISE
microtiter plate reader (Tecan, Germany).
Competition ELISA
BD Falcon
TM 96-well flexible plates were coated with 100 ng of
the p75NTRex-Fc fusion protein for each well overnight at 4uC
and blocked with FCS for 1.5 hr at 37uC. The p75NTR-specific
scFvs were added in serial dilutions. After incubation for 1.5 hr at
37uC, the plates were washed 36 with PBST. The plates were
again incubated with mouse anti-p75NTR mAb (MLR2, 1:5,000,
Abcam, UK) for 1.5 hr at 37uC and washed 36with PBST. The
scFvs and mouse anti-p75NTR mAb (MLR2) were detected by
mouse anti-His5 mAb HRP conjugated (1:5,000, Qiagen,
Germany) or goat anti-mouse IgG (Fc specific) antiserum HRP
conjugated (1:5,000, Sigma, USA), respectively. Signals were
developed and measured as described above.
Surface plasmon resonance (SPR) spectroscopy
The binding kinetics of scFvs was measured by surface plasmon
resonance spectroscopy using a Biacore2000 and a CM5 chip
(Biacore, Sweden). The antigen p75NTRex-Fc and the recombi-
nant rat TrkA/Fc chimera (rat TrkAex-Fc, R&D systems, USA)
were separately coupled on to the chip via amine coupling
according to the manufacturer’s instructions. The binding
experiment was performed at a flow rate of 30 mL/min using
PBST (0.005% peroxidase-free Tween20) at room temperature
(RT). Chip regenerations were done by 10 mM glycin buffers
(pH1.5 or pH2.0). The p75NTR-specific scFvs with concentra-
tions from 2.5 nM to 200 nM were injected with an association
time of 5 min and a dissociation time of 10 min. Curve fittings
were done using the model for 1:1 binding with drifting baseline.
Determination of intracellular expression of the p75NTR-
specific scFvs
Harvested PC12 cells were centrifuged at 3006g for 5 min after
26 washing with pre-cold PBS. Appropriated amount of lysis
buffer (1% Nonidet P-40, 10 mM Tris (pH 7.6), 150 mM NaCl,
5 mM EDTA, 1 mM PMSF, 5 mg/mL Aprotinin, 5 mg/mL
Leupeptin, 5 mg/mL Pepstatin) was used to lyse cells. After
incubated on ice for 30 min, the cells were centrifuged at 4uC,
13,4006g for 10 min. The supernatant was collected and stored at
220uC until analysis. After PAGE and blotting, the membrane
was incubated with mouse anti-His5 mAb (1:2,000, Qiagen,
Germany) for 1 hr at RT and followed by 36washing with PBST.
The membrane was subsequently incubated with goat anti-mouse
IgG antiserum (Fab-specific) alkaline phosphatase (AP) conjugated
(1:5,000, Sigma, USA) for 1 hr at RT. The bound antibodies were
visualized by NBT/BCIP substrate after 36washing with PBST.
Detection of unfolded protein response (UPR)
Transiently transfected PC12 cells from different sampling
intervals (2–8 days) were sorted by BD FACSAria
TM II gated for
the EGFP-F expression. Cell extracts were prepared from the
sorted cells. After PAGE and blotting, the membrane was
incubated with rabbit anti-GRP94 antiserum (1:1,000, Sigma,
USA) and rabbit anti-GAPDH antiserum (1:5,000, Sigma, USA)
for 1 hr at RT, separately. After 36 washing with PBST, the
membrane was subsequently incubated with goat anti-rabbit IgG
antiserum AP conjugated antibody (1:5,000, Sigma, USA) for 1 hr
at RT. The bound antibodies were visualized by NBT/BCIP
substrate.
Assay for binding to denatured p75NTR
250 ng of p75NTRex-mFc was denatured with 56 Laemmli
buffer at 95uC for 10 min. After PAGE preparation and blotting,
1 mg of each p75NTR-specific scFv-Fc recombinant antibody was
used to stain the membrane for 1.5 hr. The membrane was then
incubated with goat anti-human IgG Fc antiserum AP conjugated
antibody (1:2,000, Dianova, Germany) for 1 hr at RT and
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visualized as described above.
P75NTR surface staining and flow cytometry
A total of 2610
5 cells PC12 or NSC19 cells were transferred
into a FACS tube (Greiner, Germany). Cells were washed with
FACS buffer (2% (v/v) FCS, 5 mM EDTA in PBS) and
centrifuged at 3006 g for 5 min at 4uC. The cell pellets were
resuspended in 100 mL of the mouse anti-p75NTR mAb (MLR2,
1:200) solution or 250 ng of p75NTR-specific scFvs in 100 mL
volume, and then incubated for 1 hr on ice. The cell pellets stained
by the p75NTR-specific scFvs were washed and subsequently
resuspended with mouse anti His6-tag mAb (1:100, Roche,
Germany) in 100 mL volume and incubated for 30 min on ice.
Afterwards, all pre-stained cells were washed and incubated in
100 mL of goat anti-mouse IgG (Fcc specific) F(ab9)2 fragment
antiserum allophycocyanin (APC) conjugated (1:200, Jackson
ImmunoResearch, Germany) for 30 min on ice. After 26
washing, cells were resuspended in 500 mL of FACS buffer and
kept on ice until analysis by flow cytometry using Beckman
Coulter FC500. Data were analyzed by CXP analysis software.
Real-time quantitative reverse transcription PCR (real-
time qRT-PCR)
Total RNA was extracted from PC12 cells using RNeasy Mini
Kit (Qiagen, USA) and first-strand cDNA was synthesized by
SuperScript
TM II reverse transcriptase with Oligo (dT)12–18 primer
(ROTH, Germany) according to the manufacturer’s instructions.
The specific primers for Bcl-xL (forward: 59- CGG CGG CTG
GGA CAC TTT TG -39 and reverse: 59- CCG ACT GAA GAG
TGA GCC CAG C -39) and b-actin (forward: 59- CGG TCA
GGT CAT CAC TAT -39 and reverse: 59- TGT TGG CAT AGA
GGT CTT -39) were examined by Basic Local Alignment Search
Tool (BLASTH). For real-time qRT-PCR, the reaction mixtures
were prepared according to the manufacturer’s instruction of
SsoFast
TM EvaGreenH Supermix (Bio-Rad, Germany) and the
reactions were performed using CFX96
TM Real-time PCR system
(Bio-Rad, Germany). The reaction mixtures were pre-denatured at
95uC for 3 min, and then followed by 40 reaction cycles (95uC for
15 s; 60uC for 15 s; and 72uC for 30 s). To verify primer
specificities, melting curve analyses were performed by increasing
the temperature from 65uCt o9 5 uC (0.5uC in every 5 s). The
mRNA expression level of Bcl-xL in each sample was normalized
to the b-actin mRNA expression level. The real-time qRT-PCR
reactions were performed in triplicate.
NGF-induced differentiation of PC12 cells and
immunocytochemistry
PC 12 cells were transfected with appropriate intrabody
constructs by electroporation as described previously and plated
in poly-L-lysine coated 24-well plates in the concentration of
8610
5 cells per well. Two days after transfection, differentiation
was induced by changing medium with 500 mL of fresh culture
medium containing 200 ng/mL 2.5 s NGF (Chemicon, Ger-
many). Medium was changed every 2 days. Six days after
transfection, medium was aspirated from the wells and washed
26 with PBS. The cells were then fixed with 4% paraformalde-
hyde (PFA) at RT for 10 min and washed 36with PBS for 5 min.
The cells were stained with 100 ng/mL DAPI in PBS at RT for
5 min. Slides were then shortly washed with PBS for 3 times and
mounted upside down on slides in Fluoro-gel (Electron Micros-
copy Sciences, Germany). The slides were preserved at 4uC until
analysis with Zeiss Axiovert 200 fluorescent microscope (Zeiss,
Germany).
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